OCT News and Research

RSS

Mitochondrial proteins last much longer than expected, finds study

Mitochondria are known as the powerhouses of the cell, generating the energy that's needed to fuel the functions that our cells carry out.

28 Oct 2021

Study uncovers unknown effects of COVID-19 virus on the immune system

COVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researchers. This could affect responses to secondary infections.

28 Oct 2021

Review finds great resilience in mental health during during COVID-19 pandemic

Despite a significant but small increase in mental health symptoms early on in the COVID-19 pandemic, overall there was great resilience in mental health during 2020, University of Liverpool researchers have found.

28 Oct 2021

Novel ribosome-targeting antibiotic overcomes bacterial multidrug resistance

A new study published in Nature reports on a new antibiotic that binds to the ribosome of bacterial cells and stops drug-resistant pathogens from making mice sick.

28 Oct 2021

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy.

28 Oct 2021

Low- and middle-income parents receiving universal payments increase spending on children

When given cash with no strings attached, low- and middle-income parents increased their spending on their children, according to Washington State University research.

28 Oct 2021

Chest discomfort associated with a heart event may be felt beyond the chest

Chest discomfort associated with a heart attack or heart event may often be felt beyond the chest, with many people reporting pain in their shoulders, arms, jaw, neck, back and upper abdomen.

28 Oct 2021

Chatbot could be an effective tool to help reduce vaccine hesitancy

What if a few minutes of interaction with a chatbot could effectively address vaccine concerns? In an article published in the Journal of Experimental Psychology: Applied (28 October 2021), researchers from the CNRS, INSERM, and ENS-PSL show that such an interface is indeed capable of swaying the vaccine-hesitant.

28 Oct 2021

Unique breath test is highly accurate in identifying COVID-19 in critically ill patients

Instead of an invasive nasal swab, researchers at The Ohio State University Wexner Medical Center are exploring the use of a unique breath test for the rapid screening of patients for COVID-19.

28 Oct 2021

More strategic COVID-19 testing can reduce reliance on costly preventative interventions

Strategically increasing testing capacity, either by making diagnostic tests faster or more available, can reduce reliance on costly preventative interventions, such as distancing and shutdowns, according to a team of researchers led by Penn State.

28 Oct 2021

A new approach to selectively turn on gene therapies in target cells

Researchers at MIT and Harvard University have designed a way to selectively turn on gene therapies in target cells, including human cells.

28 Oct 2021

Diet-associated molecules in the gut are linked with aggressive prostate cancer

Cleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, suggesting dietary interventions may help reduce risk. Findings from the study were published in Cancer Epidemiology, Biomarkers & Prevention.

28 Oct 2021

'Theta activity' in the brain found to be divergent for people with mental health conditions

A new review of current literature, conducted by the Institute of Psychiatry, Psychology & Neuroscience at King's College London, has found that irregular responses in the brain to challenging tasks and mistakes could be key to understanding common links between abnormal behaviors in a range of mental illness and cognitive disorders.

28 Oct 2021

New insight into the tremendously complex "genetic dance"

The rapid scientific advancements that followed the mapping of the human genome have revealed just how staggeringly complex the world of genetics is.

28 Oct 2021

Study offers hope for a new therapeutic option for patients with severe asthma

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.

28 Oct 2021

Research finds variability in PTSD symptoms over the course of menstrual cycle

In women who have experienced trauma, post-traumatic stress disorder symptoms may vary over the course of the menstrual cycle, with more symptoms during the first few days of the cycle when the hormone estradiol is low, and fewer symptoms close to ovulation, when estradiol is high, finds research published by the American Psychological Association.

28 Oct 2021

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust and UCL have found immune cell patterns within tumors that can help predict if patients with kidney cancer will respond to immunotherapy.

28 Oct 2021

Five-day course of preoperative radiation therapy for sarcoma provides excellent local control rates

In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found that dose-equivalent preoperative radiation therapy for extremity/trunk soft tissue sarcoma delivered in five days rather than over the conventional five weeks produced similar benefits and treatment side effects.

28 Oct 2021

OSU research shines light on the way malignant cancer cells change shape

Oregon State University research has shed new light on the way malignant cells change their shape and migration techniques to invade different types of tissue.

28 Oct 2021

A low-cost repurposed drug can save COVID-19 patients' lives

An inexpensive repurposed drug called fluvoxamine can save the lives of COVID-19 patients and cut hospital admissions by up to 30 per cent, says a study co-led by McMaster University.

27 Oct 2021

OCT News and Research

Mitochondrial proteins last much longer than expected, finds study

Study uncovers unknown effects of COVID-19 virus on the immune system

Review finds great resilience in mental health during during COVID-19 pandemic

Novel ribosome-targeting antibiotic overcomes bacterial multidrug resistance

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

Low- and middle-income parents receiving universal payments increase spending on children

Chest discomfort associated with a heart event may be felt beyond the chest

Chatbot could be an effective tool to help reduce vaccine hesitancy

Unique breath test is highly accurate in identifying COVID-19 in critically ill patients

More strategic COVID-19 testing can reduce reliance on costly preventative interventions

A new approach to selectively turn on gene therapies in target cells

Diet-associated molecules in the gut are linked with aggressive prostate cancer

'Theta activity' in the brain found to be divergent for people with mental health conditions

New insight into the tremendously complex "genetic dance"

Study offers hope for a new therapeutic option for patients with severe asthma

Research finds variability in PTSD symptoms over the course of menstrual cycle

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Five-day course of preoperative radiation therapy for sarcoma provides excellent local control rates

OSU research shines light on the way malignant cancer cells change shape

A low-cost repurposed drug can save COVID-19 patients' lives

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News